Since becoming Ministry of Defense director general in March, Amir Baram has led a substantial change in the pace of progress ...

With a unique business model rooted in innovation-led drug development services, the company is betting big on global ...

At the midpoint of 2025, initial public offerings are in acceleration mode, with a slew of stocks newly trading in the past month and several potential big-name IPO targets on the way.

Bajaj Broking Research says investor sentiment was buoyant in FY22, driven by excess liquidity and optimism surrounding India ...

IN RECENT weeks, two relatively large initial public offers (IPOs) were announced: NTT’s data centre real estate investment ...

Total fundraising this year is projected to nearly double 2024 levels. In a recent report, Savills said the Hong Kong IPO ...

Since its June 5 trading debut, stablecoin issuer Circle's (CRCL) stock has climbed more than 500%. The rising provider has issued over $61 billion worth of its stablecoin USD Coin (USDC-USD), making ...

Comparative assessments and other editorial opinions are those of U.S. News and have not been previously reviewed, approved ...

CoreWeave was founded as Atlantic Crypto, an Ethereum miner, but pivoted its business model in the crypto winter of 2018-2019 ...

Web design tools developer Figma on Tuesday filed with the US Securities and Exchange Commission to propose an initial public ...

Panera Bread has been seeing an increase in visitors, which bodes well for a possible IPO, says analytics company Placer.ai Last Updated: April 8, 2024 at 8:54 a.m. ET First Published: April 5 ...

Summary. Apogee Therapeutics, Inc. has filed proposed terms for a $250 million IPO. The firm is developing drug treatment candidates for atopic dermatitis, COPD and asthma.